Commentary: Efficacy and safety of the innovative monoclonal antibodies in adults with generalized myasthenia gravis: a Bayesian network analysis

• Ina Zhang,
• Jeroen P. Jansen,
• Benjamin J. Yungher,
• Adrian Kielhorn,
• Karen S. Yee

Affiliations

Ina Zhang

Evidence Synthesis and Decision Modeling, PRECISIONheor, Oakland, CA, United States

Jeroen P. Jansen

Evidence Synthesis and Decision Modeling, PRECISIONheor, Oakland, CA, United States

Benjamin J. Yungher

Alexion, AstraZeneca Rare Disease, Boston, MA, United States

Adrian Kielhorn

Alexion, AstraZeneca Rare Disease, Boston, MA, United States

Karen S. Yee

Alexion, AstraZeneca Rare Disease, Boston, MA, United States